rs121912651
|
|
Abnormality of the tongue
|
A |
0.700 |
CausalMutation
|
CLINVAR |
|
|
|
rs121912651
|
|
Adenocarcinoma of lung (disorder)
|
C |
0.710 |
GeneticVariation
|
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs121912651
|
|
Adenocarcinoma of lung (disorder)
|
A |
0.710 |
GeneticVariation
|
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs121912651
|
|
Adenocarcinoma of lung (disorder)
|
|
0.710 |
GeneticVariation
|
BEFREE |
To further investigate the mechanism of pemetrexed resistance and potential prognostic outcomes in lung cancer, we established pemetrexed-resistant lung adenocarcinoma cell sublines from CL1 harboring a mutated TP53 gene (R248W) and A549 harboring wild-type TP53.
|
27270426 |
2017 |
rs121912651
|
|
Adenocarcinoma of pancreas
|
A |
0.700 |
GeneticVariation
|
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs121912651
|
|
Adenocarcinoma of pancreas
|
C |
0.700 |
GeneticVariation
|
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs121912651
|
|
Adenocarcinoma of prostate
|
C |
0.700 |
GeneticVariation
|
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs121912651
|
|
Adenocarcinoma of prostate
|
A |
0.700 |
GeneticVariation
|
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs121912651
|
|
Anaplastic thyroid carcinoma
|
|
0.010 |
GeneticVariation
|
BEFREE |
Adoptive overexpression of wild-type p53, but not of its inactive (R248W and R273H) mutants, strongly down-regulated transcription from the MCM7 promoter, suggesting that p53 knock-out contributes to MCM7 up-regulation in ATC.
|
15899946 |
2005 |
rs121912651
|
|
Brain Neoplasms
|
C |
0.700 |
GeneticVariation
|
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs121912651
|
|
Brain Neoplasms
|
A |
0.700 |
GeneticVariation
|
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs121912651
|
|
Brain Stem Glioma
|
A |
0.700 |
GeneticVariation
|
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs121912651
|
|
Brain Stem Glioma
|
C |
0.700 |
GeneticVariation
|
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs121912651
|
|
Carcinogenesis
|
|
0.010 |
GeneticVariation
|
BEFREE |
Several lines of evidence further indicate gain-of-function of p53 mutants in promoting tumorigenesis. p53(R248W) mice rapidly succumb to certain types of cancers not commonly observed in p53(-/-) mice.
|
17417627 |
2007 |
rs121912651
|
|
Carcinoma
|
|
0.010 |
GeneticVariation
|
BEFREE |
A homozygous p53 R248W gain-of-function mutation as the result of a CGG to TGG transition was identified in one of seven sebaceous gland carcinomas.
|
18717684 |
2008 |
rs121912651
|
|
Central neuroblastoma
|
|
0.010 |
GeneticVariation
|
BEFREE |
It remains unclear at this time whether a similar association of NB and R248W in patients with LFS exists.
|
17427234 |
2008 |
rs121912651
|
|
Childhood Neuroblastoma
|
|
0.010 |
GeneticVariation
|
BEFREE |
It remains unclear at this time whether a similar association of NB and R248W in patients with LFS exists.
|
17427234 |
2008 |
rs121912651
|
|
Chronic graft-versus-host disease
|
|
0.010 |
GeneticVariation
|
BEFREE |
Moreover, the detection of pathogenic variants, including single nucleotide substitution of TP53 (c.346C>T) and BRCA2 (c.6952C>T) and splicing of KDM6A (c.1194+2T>G), suggest that the development of ESCC in the patient was triggered by impairment of checkpoint and repair for DNA damage and epigenetic modification through accumulation of gene mutations induced by chronic graft-versus-host disease and prolonged administration of tacrolimus.
|
30499911 |
2018 |
rs121912651
|
|
Chronic Lymphocytic Leukemia
|
A |
0.700 |
GeneticVariation
|
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs121912651
|
|
Chronic Lymphocytic Leukemia
|
C |
0.700 |
GeneticVariation
|
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs121912651
|
|
Colorectal Carcinoma
|
C |
0.700 |
GeneticVariation
|
CLINVAR |
|
|
|
rs121912651
|
|
Colorectal Neoplasms
|
C |
0.700 |
GeneticVariation
|
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs121912651
|
|
Colorectal Neoplasms
|
A |
0.700 |
GeneticVariation
|
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs121912651
|
|
Congenital pectus excavatum
|
A |
0.700 |
CausalMutation
|
CLINVAR |
|
|
|
rs121912651
|
|
Cutaneous Melanoma
|
C |
0.700 |
GeneticVariation
|
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |